Latest Headlines

31. Pharus Diagnostics LLC Announces Validation Of A Laboratory-Developed Test For Early Pancreatic Cancer Detection 12/18/2024

    Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer.

32. Hologic To Contribute To H5N1 Bird Flu Test Development Via Agreement Issued By CDC 12/18/2024

    Hologic, Inc. today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests used to identify specific diseases or conditions — that would aid in the detection of H5N1 bird flu.

33. Merck To Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio 12/17/2024

    Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ.

34. TruDiagnostic Introduces Revolutionary Epigenetic Biomarker Proxies: New Diagnostic Approach Outperforms Traditional Lab Results 12/17/2024

    TruDiagnostic, a global leader in advanced epigenetic research, proudly announces a groundbreaking advancement in precision medicine: the development of Epigenetic Biomarker Proxies (EBPs). This transformative way of measuring biological function delivers unprecedented capabilities in disease prediction and diagnosis, using just a single drop of blood.

35. BD And Babson Diagnostics Launch Innovative Fingertip Blood Testing To Health Care Organizations 12/17/2024

    BD (Becton, Dickinson and Company), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S.

36. A Normal Blood Test Result Might Not Be Normal For You 12/14/2024

    Personalizing the most common lab test used in medicine, the complete blood count, may improve diagnosis and care.

37. Luminodx Announces CLIA Certification For San Diego Laboratory 12/12/2024

    LuminoDx is pleased to announce that its San Diego laboratory has recently received Clinical Laboratory Improvement Amendments (CLIA) certification.

38. ZEISS And Mindpeak Partner To Advance Multiplex Immunofluorescence (mIF) Solutions For Pathology 12/12/2024

    ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications.

39. Medical Metrics And Micron Announce Global Imaging Services Collaboration 12/12/2024

    US-based Medical Metrics, Inc. (MMI) and Japan-based Micron, Inc. (Micron) are teaming up to create a unique, global imaging core lab offering for clinical trials across multiple therapeutic areas.

40. Exagen Inc. Achieves Key Milestone With 1,000,000^th Patient Tested By AVISE® CTD 12/12/2024

    Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant milestone that underscores the company’s dedication to supporting patients and clinicians managing connective tissue diseases (CTD) and other autoimmune conditions.